Antiepithelial-derived Cytokines Need Targeting for Asthma
Data from a meta-analysis suggest that patients with low eosinophil counts derive little benefit from these therapies.
Source: medscape.com
Stay updated with breaking news from Type 2 Asthma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data from a meta-analysis suggest that patients with low eosinophil counts derive little benefit from these therapies.
Type 2 inflammation may be causative in bronchiectasis in patients with type 2-high severe asthma. Its early diagnosis is critical to improve outcomes in patients with this dual diagnosis.
Treatment with itepekimab, a new human IgG4P monoclonal antibody against interleukin-33, led to a reduction in events indicating loss of asthma control.